Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes – (Eye 30, 763 (May 2016))
Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes Eye 30, 763 (May 2016). doi:10.1038/eye.2015.281 Authors: A Kumar, Q Alfahad, A Mitra, S Elsherbiny & P L Lip
Cannula-associated ocular injuries during cataract surgery: the North East England Study – (Eye 30, 764 (May 2016))
Cannula-associated ocular injuries during cataract surgery: the North East England Study Eye 30, 764 (May 2016). doi:10.1038/eye.2016.3 Authors: D S J Ting, D Vaideanu-Collins & C Ellerton
Comment on: ‘Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab’ – (Eye 30, 766 (May 2016))
Comment on: ‘Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab’ Eye 30, 766 (May 2016). doi:10.1038/eye.2016.2 Authors: D Călugăru & M Călugăru
Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab’ – (Eye 30, 766 (May 2016))
Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab’ Eye 30, 766 (May 2016). doi:10.1038/eye.2016.6 Authors: T D Papakostas, D Vavvas, D Eliott & L A Kim
Is intraocular pressure the only important postoperative variable? The role of first day postoperative review after vitrectomy – (Eye 30, 767 (May 2016))
Is intraocular pressure the only important postoperative variable? The role of first day postoperative review after vitrectomy Eye 30, 767 (May 2016). doi:10.1038/eye.2016.4 Authors: K B Harshey & R Madhukumar